Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (FCRX) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to $1.6 billion.

  • Crescent Capital BDC's Liabilities and Shareholders Equity fell 105.9% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 60.34%. This contributed to the annual value of $1.7 billion for FY2024, which is 177.56% up from last year.
  • As of Q3 2025, Crescent Capital BDC's Liabilities and Shareholders Equity stood at $1.6 billion, which was down 105.9% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's Liabilities and Shareholders Equity ranged from a high of $1.7 billion in Q2 2024 and a low of $1.3 billion during Q4 2022
  • In the last 5 years, Crescent Capital BDC's Liabilities and Shareholders Equity had a median value of $1.6 billion in 2023 and averaged $1.5 billion.
  • As far as peak fluctuations go, Crescent Capital BDC's Liabilities and Shareholders Equity plummeted by 113.3% in 2022, and later soared by 2490.65% in 2023.
  • Crescent Capital BDC's Liabilities and Shareholders Equity (Quarter) stood at $1.3 billion in 2021, then decreased by 1.13% to $1.3 billion in 2022, then rose by 24.91% to $1.6 billion in 2023, then increased by 1.78% to $1.7 billion in 2024, then decreased by 1.73% to $1.6 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.6 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.7 billion in Q1 2025.